Clinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs

Authors :: Chiara Catania
G. Rossi
F. De Marinis
Elena Guerini-Rocco
E. Del Signore
Antonio Passaro
A. Prelaj
Gianluca Spitaleri
Massimo Barberis
Source :: Annals of Oncology. 30:ii54
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
medicine.medical_specialty
5 year survival rate
business.industry
Internal medicine
medicine
ALK-Positive
Hematology
Lung cancer
medicine.disease
business
Survival rate

Tools